Two directors resign from Apimeds Pharmaceuticals board effective December 5, 2025

Apimeds Pharmaceuticals US, Inc.

Dr. Vin Menon and Amir A. Dossal resigned from the Board of Directors on December 5, 2025.
Resignations were not due to any disagreement with the company's operations, policies, or practices.
Dr. Vin Menon remains CEO of the company; no replacements for the vacant board seats announced.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.